epitan melanotan I Melanotan II (MT-2)

In healthy, resting cells, the ratio of reduced glutathione to oxidized glutathione is typically greater than 100:1

Some are already widely used as medicines

Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience

There is: No evidence that Epitalon can shrink existing tumors in humans No human clinical trials testing its use in oncology No mechanistic studies confirming how Epitalon affects tumor microenvironments or immune evasion in vivo What we do have is a compelling preventive profile in animal models, especially where aging and genetic susceptibility intersect